Skip to main content
Novosanis
Menu
About us
Products
Home collection
Dataroom
News & Events
News
Infographics
Blogs
Press releases
Events
Podcasts & Webinars
Contact
Careers
FAQs
Search
Search
Press releases
You are here
Home
»
Press releases
Novosanis launches volume variants of Colli-Pee® offering new applications in urine testing
We are excited to announce the launch of volume variants of Colli-Pee ® , our innovative urine-capturing device...
8/10/2019
Read more
Novosanis enters into distribution deal with Fujirebio
Novosanis announces deal with Fujirebio, a global leader in the field of in vitro diagnostics (IVD). Using our Colli-...
4/04/2019
Read more
Novosanis acquired by OraSure Technologies Inc
Wijnegem, Belgium, January 8, 2019: Novosanis, a privately-held, Belgian company founded as a spinoff company from the...
8/01/2019
Read more
European Patent granted for Colli-Pee
Novosanis announced today that the European Patent Office (EPO) has granted the company's patent application in Europe...
30/11/2018
Read more
Colli-Pee approved by Mexican Health Authority
Wijnegem, Belgium, November 8, 2018: Novosanis, an innovative developer and producer of medical devices, announced...
8/11/2018
Read more
Novosanis obtains regulatory approval for Colli-Pee in Brazil
Wijnegem, Belgium, July 26 2018: Novosanis announced today that Colli-Pee a non-invasive self-sampling device suited...
25/07/2018
Read more
Colli-Pee with UCM preservative CE certified
Novosanis, an innovative developer and producer of medical devices, announced today that Colli-Pee, a self-sampling...
30/03/2018
Read more
Colli-Pee recognized at the prestigious Henry Van de Velde Awards
Novosanis and Voxdale have been awarded the prestigious Henry Van de Velde Award in Design for Healthcare.
7/02/2018
Read more
Novosanis receives Interreg CrossCare grant for its Colli-Pee™ device
Interreg CrossCare grant allows Novosanis to build a next-generation Colli-Pee™ device
4/04/2017
Read more
Novosanis signs agreement with MDxHealth
Novosanis develops UrNCollect TM for SelectMDx for Prostate Cancer IVD kit of MDxHealth
23/03/2017
Read more
First CE marked HPV test offering possibility to use first-void urine
Novosanis, a medical device company based in Wijnegem Belgium, together with GeneFirst, a molecular diagnostic company...
31/10/2016
Read more
Novosanis participates in Belgian Royal Mission to Japan
Novosanis considers Japan as an important market due to its innovative vision towards healthcare and diagnostics.
11/10/2016
Read more
Pages
1
2
next ›
last »